1. Randomized Controlled Trial of a Collaborative Care Intervention for Mood Disorders by a National Commercial Health Plan
- Author
-
Hyong Un, Mark S. Bauer, Katherine Prenovost, Hyungjin Myra Kim, Celeste Liebrecht, Daniel Eisenberg, and Amy M. Kilbourne
- Subjects
Adult ,Male ,medicine.medical_specialty ,Collaborative Care ,Population health ,Article ,law.invention ,Insurance Claim Review ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Intervention (counseling) ,Humans ,Medicine ,Single-Blind Method ,030212 general & internal medicine ,Bipolar disorder ,Cooperative Behavior ,Psychiatry ,Depression (differential diagnoses) ,Aged ,Patient Care Team ,Psychiatric Status Rating Scales ,Chronic care ,Primary Health Care ,Mood Disorders ,business.industry ,Disease Management ,Middle Aged ,medicine.disease ,United States ,030227 psychiatry ,Psychiatry and Mental health ,Logistic Models ,Mood disorders ,Chronic Disease ,Quality of Life ,Female ,business - Abstract
OBJECTIVE: Mood disorders lead to significant functional impairment and are the costliest conditions for health plans. Few individuals with mood disorders have access to evidence-based Collaborative Chronic Care Models (CCMs) because most are seen in small-group practices (
- Published
- 2019